Style and quality now lead the reasons shoppers give for their most recent purchase, ahead of price and promotions. More than ...
CG Oncology is well-positioned to enter a de-risked NMIBC market with cretostimogene. Click here to read why CGON stock is a ...
Oncologists weighted how to choose, manage, and deliver new therapeutics beyond major academic centers. Across many disease ...
October 23, 2026 - DelveInsight's " BCG-Unresponsive Non-Muscle Invasive Bladder Cancer – Market Insights, Epidemiology, and Market Forecast – 2034 " report delivers an in-depth understanding of ...
BCG vaccination reduced tau pathology and neuroinflammation in mice, prompting researchers to investigate whether trained immunity could inform future treatments for Alzheimer’s disease.
Database lock completed for Cohort A of QUILT-2.005 (NCT02138734), a randomized, controlled registrational trial comparing ANKTIVA® plus BCG with BCG alone in 366 patients with BCG-naïve non-muscle ...
Based on early research, @HopkinsMedicine investigators are moving the field closer to understanding links between the #Tuberculosis vaccine and reduced risks for #Dementia while expanding knowledge ...
Since BCG's 2024 AI Maturity Matrix, Japan and South Korea Join Canada, Mainland China, Singapore, the UK, and the US as AI Pioneers New BCG Research Finds AI Readiness Has Significantly Advanced ...
New BCG Survey Reveals 65% of Revenue Leaders Expect Headcount to Grow, 72% Expect Budgets to Rise, and 91% Expect Higher Quotas or Productivity Requirements per SellerAI Expected to Help ...
(NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that the U.S. Food and Drug Administration (FDA) has expanded the approved indication for ANKTIVA ® (nogapendekin alfa ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results